2024 |
Opko Health Inc
|
Lead Independent Director |
119.8 K |
-11.1 % |
2024 |
GeneDx Holdings Corp - Ordinary Shares - Class A
|
Independent Director |
- |
- |
2023 |
GeneDx Holdings Corp - Ordinary Shares - Class A
|
Independent Director |
147.0 K |
-68.1 % |
2023 |
Opko Health Inc
|
Lead Independent Director |
134.8 K |
-22.6 % |
2023 |
Cocrystal Pharma Inc
|
Independent Director |
44.2 K |
-22.0 % |
2022 |
GeneDx Holdings Corp - Warrants (22/07/2026)
|
Director |
460.4 K |
- |
2022 |
GeneDx Holdings Corp - Ordinary Shares - Class A
|
- |
460.4 K |
- |
2022 |
Opko Health Inc
|
Lead Independent Director |
174.2 K |
-7.6 % |
2022 |
Cocrystal Pharma Inc
|
Independent Director |
56.7 K |
-8.5 % |
2022 |
Fluent Inc
|
Independent Director |
- |
- |
2021 |
Opko Health Inc
|
Lead Independent Director |
188.5 K |
68.3 % |
2021 |
Cocrystal Pharma Inc
|
Independent Director |
62 K |
- |
2021 |
BioCardia Inc.
|
Independent Director |
- |
- |
2020 |
BioCardia Inc.
|
Independent Director |
168.0 K |
263.3 % |
2020 |
Opko Health Inc
|
Lead Independent Director |
112 K |
68.4 % |
2019 |
Opko Health Inc
|
Independent Director |
66.5 K |
-30.0 % |
2019 |
BioCardia Inc.
|
Independent Director |
46.3 K |
- |
2018 |
Opko Health Inc
|
Independent Director |
95 K |
-13.4 % |
2017 |
Opko Health Inc
|
Independent Director |
109.7 K |
11.3 % |
2016 |
Opko Health Inc
|
Independent Director |
98.6 K |
-21.1 % |
2015 |
Opko Health Inc
|
Independent Director |
125 K |
9.5 % |
2014 |
Opko Health Inc
|
Independent Director |
114.2 K |
63.1 % |
2013 |
Opko Health Inc
|
Independent Director |
70 K |
16.7 % |
2012 |
Opko Health Inc
|
Independent Director |
60 K |
17.6 % |
2011 |
Opko Health Inc
|
Independent Director |
51 K |
34.3 % |
2010 |
Opko Health Inc
|
Independent Director |
38.0 K |
18.9 % |
2009 |
Opko Health Inc
|
Director |
31.9 K |
-61.8 % |
2008 |
Opko Health Inc
|
Director |
83.6 K |
- |
2007 |
Opko Health Inc
|
Director |
- |
- |